Erratum to 'Efficacy and Safety of Darolutamide in Patients with Nonmetastatic Castration-resistant Prostate Cancer Stratified by Prostate-specific Antigen Doubling Time: Planned Subgroup Analysis of the Phase 3 ARAMIS Trial' [Eur Urol 2022]

Subjects

Subjects :

Urology

Details

ISSN :

03022838

Volume :

83

Database :

OpenAIRE

Journal :

European Urology

Accession number :

edsair.doi...........2930ad9fc8e8c29f23af175a7111900a

Full Text :

https://doi.org/10.1016/j.eururo.2022.11.018